au.\*:("MARECHAL, Raphaël")
Results 1 to 5 of 5
Selection :
Adjuvant Pharmacotherapy in the Management of Elderly Patients with Pancreatic CancerMARECHAL, Raphaël; DEMOLS, Anne; VAN LAETHEM, Jean-Luc et al.Drugs & aging. 2013, Vol 30, Num 3, pp 155-165, issn 1170-229X, 11 p.Article
Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic AdenocarcinomaMARECHAL, Raphaël; MACKEY, John R; LAI, Raymond et al.Cancer. 2010, Vol 116, Num 22, pp 5200-5206, issn 0008-543X, 7 p.Article
Human Equilibrative NucleosideTransporter 1 and Human Concentrative NucleosideTransporter 3 Predict Survival after Adjuvant GemcitabineTherapy in Resected Pancreatic AdenocarcinomaMARECHAL, Raphaël; MACKEY, John R; VAN LAETHEM, Jean-Luc et al.Clinical cancer research (Print). 2009, Vol 15, Num 8, pp 2913-2919, issn 1078-0432, 7 p.Article
The lnterleukin-17 Pathway Is Involved in Human Alcoholic Liver DiseaseLEMMERS, Arnaud; MORENO, Christophe; LE MOINE, Olivier et al.Hepatology (Baltimore, Md.). 2009, Vol 49, Num 2, pp 646-657, issn 0270-9139, 12 p.Article
S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinomaBACHET, Jean-Baptiste; MARECHAL, Raphael; PAYE, François et al.European journal of cancer (1990). 2013, Vol 49, Num 12, pp 2643-2653, issn 0959-8049, 11 p.Article